Identification of 60 secreted proteins for Mycoplasma bovis with secretome assay.
Antibodies, Bacterial
/ immunology
Bacterial Proteins
/ genetics
Conserved Sequence
/ genetics
Electrophoresis, Gel, Two-Dimensional
Genome, Bacterial
/ genetics
Genomics
Mass Spectrometry
Mycoplasma bovis
/ genetics
Proteomics
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Virulence
Genome
M. bovis
Proteomics
Secreted proteins
Secretome
Virulence
Journal
Microbial pathogenesis
ISSN: 1096-1208
Titre abrégé: Microb Pathog
Pays: England
ID NLM: 8606191
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
04
11
2019
revised:
13
02
2020
accepted:
06
03
2020
pubmed:
14
3
2020
medline:
30
3
2021
entrez:
14
3
2020
Statut:
ppublish
Résumé
Mycoplasma bovis is a risky pathogen mainly responsible for pneumonia and mastitis in cattle. Up to date, its pathogenesis is not clear. Since secreted proteins have a tricky role in M. bovis pathogenesis, this study was designed to systematically reveal M. bovis secretome and potential role in virulence of the pathogen. By using bioinformatics tools, a total of 246 secreted proteins were predicted based on M. bovis genome. Among them, 14 were classical, 154 non-classical and 78 both pathways. Then by using 2-dimensional gel electrophoresis (2-DE) and Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF- MS), 169 proteins were revealed. Of them, 60 were predicted to be secreted including 3 classical, 43 non-classical, and 14 both classical and non-classical. Further 8 proteins (MbovP0038, MbovP0338, MbovP0341, MbovP0520, MbovP0581, MbovP0674, MbovP0693, MbovP0845) were predicted to be virulence-related factors with VFDB. In addition, MbovP0581 (ABC transporter protein) was validated experimentally as secreted in nature and highly immunogenic reacting with sera of cattle experimentally infected with M. bovis. In conclusion, this study might be a crucial step towards a better understanding of pathogenesis and leading to the development of novel diagnostic marker and potent vaccine against M. bovis.
Identifiants
pubmed: 32165330
pii: S0882-4010(20)30422-8
doi: 10.1016/j.micpath.2020.104135
pii:
doi:
Substances chimiques
Antibodies, Bacterial
0
Bacterial Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104135Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflict of interest.